9.83
price up icon3.69%   0.35
after-market Handel nachbörslich: 10.00 0.17 +1.73%
loading
Schlusskurs vom Vortag:
$9.48
Offen:
$9.51
24-Stunden-Volumen:
78,813
Relative Volume:
0.86
Marktkapitalisierung:
$30.36M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-5.1466
EPS:
-1.91
Netto-Cashflow:
$-85.33M
1W Leistung:
+5.02%
1M Leistung:
+20.47%
6M Leistung:
-51.46%
1J Leistung:
-48.28%
1-Tages-Spanne:
Value
$9.318
$9.88
1-Wochen-Bereich:
Value
$8.88
$10.39
52-Wochen-Spanne:
Value
$6.76
$30.00

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name
Firmenname
Aligos Therapeutics Inc
Name
Telefon
(800) 466-6059
Name
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Name
Mitarbeiter
68
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
ALGS's Discussions on Twitter

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-01-06 Hochstufung Jefferies Hold → Buy
2023-01-06 Hochstufung Piper Sandler Neutral → Overweight
2022-03-23 Herabstufung Piper Sandler Overweight → Neutral
2022-01-07 Herabstufung JP Morgan Overweight → Neutral
2022-01-06 Herabstufung Jefferies Buy → Hold
2021-09-09 Eingeleitet SVB Leerink Outperform
2021-05-17 Fortgesetzt Piper Sandler Overweight
2020-11-10 Eingeleitet Cantor Fitzgerald Overweight
2020-11-10 Eingeleitet JP Morgan Overweight
2020-11-10 Eingeleitet Jefferies Buy
2020-11-10 Eingeleitet Piper Sandler Overweight
Alle ansehen

Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten

pulisher
Oct 30, 2024

Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024 - StockTitan

Oct 30, 2024
pulisher
Oct 27, 2024

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Drop in Short Interest - MarketBeat

Oct 27, 2024
pulisher
Oct 27, 2024

Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 5.4% – Here’s What Happened - Defense World

Oct 27, 2024
pulisher
Oct 25, 2024

Aligos Therapeutics (NASDAQ:ALGS) Trading Down 5.4%Here's What Happened - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

HC Wainwright Reiterates Buy Rating for Aligos Therapeutics (NASDAQ:ALGS) - Defense World

Oct 25, 2024
pulisher
Oct 24, 2024

Aligos Therapeutics (NASDAQ:ALGS) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

Aligos Therapeutics' (ALGS) Buy Rating Reiterated at HC Wainwright - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184 - The Manila Times

Oct 22, 2024
pulisher
Oct 18, 2024

Aligos Therapeutics: ALG-055009 reduces liver fatty deposits in patients with metabolic-dysfunction associated steatohepatitis (MASH) - 2 Minute Medicine

Oct 18, 2024
pulisher
Oct 15, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Gap UpWhat's Next? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 202 - The Manila Times

Oct 15, 2024
pulisher
Oct 14, 2024

Aligos Therapeutics (NASDAQ:ALGS) Trading Down 8.4%Should You Sell? - MarketBeat

Oct 14, 2024
pulisher
Oct 11, 2024

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 11, 2024
pulisher
Oct 10, 2024

Aligos Therapeutics (NASDAQ:ALGS) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Significant Increase in Short Interest - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Aligos Therapeutics (NASDAQ:ALGS) Trading 4.9% HigherStill a Buy? - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

ALGS stock touches 52-week low at $7.22 amid market challenges By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Aligos Therapeutics (NASDAQ:ALGS) Hits New 1-Year LowWhat's Next? - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

ALGS stock touches 52-week low at $7.22 amid market challenges - Investing.com Australia

Oct 08, 2024
pulisher
Oct 07, 2024

When the Price of (ALGS) Talks, People Listen - Stock Traders Daily

Oct 07, 2024
pulisher
Oct 04, 2024

Aligos TherapeuticsIt's All About Chronic Hepatitis B - RTTNews

Oct 04, 2024
pulisher
Oct 03, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Aligos Therapeutics (NASDAQ:ALGS) Trading Down 6.2%Should You Sell? - MarketBeat

Oct 03, 2024
pulisher
Oct 01, 2024

Aligos Therapeutics appoints new VP of Business Development By Investing.com - Investing.com Australia

Oct 01, 2024
pulisher
Oct 01, 2024

Aligos Therapeutics appoints new VP of Business Development - Investing.com

Oct 01, 2024
pulisher
Oct 01, 2024

Aligos Therapeutics Appoints David Perry as Vice President of Business Development - The Manila Times

Oct 01, 2024
pulisher
Sep 30, 2024

Aligos Therapeutics to Present at Investor Conferences in October - The Manila Times

Sep 30, 2024
pulisher
Sep 26, 2024

(ALGS) Investment Analysis and Advice - Stock Traders Daily

Sep 26, 2024
pulisher
Sep 25, 2024

Aligos Therapeutics keeps stock target, overweight rating on promising data By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 25, 2024

Aligos Therapeutics names new chief medical officer By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 24, 2024

Aligos Therapeutics keeps stock target, overweight rating on promising data - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

ALGSAligos Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Sep 24, 2024
pulisher
Sep 24, 2024

Aligos Therapeutics names new chief medical officer - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer - StockTitan

Sep 24, 2024
pulisher
Sep 23, 2024

Aligos Therapeutics stock hits 52-week low at $8.5 - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Aligos Therapeutics stock hits 52-week low at $8.5 By Investing.com - Investing.com Canada

Sep 23, 2024
pulisher
Sep 23, 2024

Aligos Therapeutics (NASDAQ:ALGS) Sets New 52-Week Low at $8.28 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Aligos Therapeutics (NASDAQ:ALGS) Reaches New 52-Week Low at $8.28 - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Gap Down to $14.16 - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Aligos Therapeutics' (ALGS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Gap Up to $10.18 - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Aligos Therapeutics (NASDAQ:ALGS) Earns “Buy” Rating from HC Wainwright - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Market Recap Check: Aligos Therapeutics Inc (ALGS)’s Negative Finish at 10.18, Up/Down -28.11 - The Dwinnex

Sep 20, 2024
pulisher
Sep 20, 2024

Aligos Phase II results for ALG-055009 in MASH fail to impress - The Pharma Letter

Sep 20, 2024
pulisher
Sep 20, 2024

Aligos shares maintain Buy rating with price target after study - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Aligos reports positive data from Phase IIa MASH treatment trial - Clinical Trials Arena

Sep 20, 2024
pulisher
Sep 20, 2024

Aligos reports progress in MASH treatment study - Investing.com

Sep 20, 2024

Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):